Currently out of the existing stock ratings of Edward Woo, 215 are a BUY (94.3%), 6 are a SELL (2.63%), 7 are a HOLD (3.07%).

Edward Woo

Work Performance Price Targets & Ratings Chart

Analyst Edward Woo, currently employed at ASCENDIANT, carries an average stock price target met ratio of 44.29% that have a potential upside of 52.36% achieved within 221 days.

Edward Woo’s has documented 419 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Communication Services, Consumer Cyclical, Energy, Technology sectors.

Most recent stock forecast was given on SURG, Surgepays at 16-Jun-2025.

Wall Street Analyst Edward Woo

Analyst best performing recommendations are on HSCS (HEART TEST LABORATORIES COMMON STOCK).
The best stock recommendation documented was for HSCS (HEART TEST LABORATORIES COMMON STOCK) at 1/30/2023. The price target of $330 was fulfilled within 4 days with a profit of $95 (40.43%) receiving and performance score of 101.06.

Average potential price target upside

of $368.41 (18.41%) on BKNG (BOOKING HOLDINGS).
of $33.26 (22.68%) on TTWO (TAKE-TWO INTERACTIVE SOFTWARE).
of $23.15 (20.61%) on EA (ELECTRONIC ARTS).

ATOS Atossa Genetics ATVI Activision Blizzard BIOL BIOLASE BKNG Booking Holdings EA Electronic Arts ENSV Enservco Co EXPE Expedia Group GME GameStop Corp GNSS Genasys GRPN Groupon JAKK JAKKS Pacific MYO Myomo NBY NovaBay Pharmaceuticals NDRA ENDRA Life Sciences OTLK OUTLOOK THERAPEUTICS INC PCOM Points International Ltd. PHUN Phunware PSTV Plus Therapeutics SINT SINTX Technologies TRIP TripAdvisor TTWO Take-Two Interactive Software TZOO Travelzoo VERB VERB TECHNOLOGY COMPANY INC WISA WiSA Technologies AUTO Autoweb LUCD Lucid Diagnostics IMAC Imac Holdings PAVM PAVmed SURG Surgepays VVOS Vivos Therapeutics INTZ Intrusion NRXP NRX Pharmaceuticals HSCS Heart Test Laboratories Common Stock AMTX Aemetis SOPA Society Pass RNXT RenovoRx BSGM BioSig Technologies, Common Stock ALZN Alzamend Neuro BLBX Blackboxstocks CING Cingulate COCH Envoy Medical DUOT Duos Technologies Group DXR Daxor GRI GRI Bio AIM AIM ImmunoTech

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Edward Woo (ASCENDIANT)